Drug Utilization Review (DUR) Board
The purpose of the Indiana Medicaid DUR Board is to serve in an
advisory capacity to Indiana Medicaid with regard to the dispensing
of drugs by Indiana Medicaid-enrolled providers and the use of
drugs by Indiana Medicaid members. The board is composed of
representatives of the pharmacy, medical, and scientific
communities and has a responsibility to establish criteria for both
retrospective review and prospective surveillance of drug
dispensing for and use by Indiana Medicaid members. Through the
expert opinion of the board members, aided when appropriate by
consultants, the board provides the Medicaid agency with advice on
matters of drug usage to allow for appropriate and cost-effective
delivery of medical and pharmaceutical care.
Regular meetings are held to review issues relating to the
board. This site contains the meeting schedule and agenda for
upcoming meetings. Meeting minutes are also available for prior
meetings. If you would like to submit a topic for discussion at a
board meeting, please add your name to the speaker sign-in
sheet.
Board Members
| Name |
Board Title |
Residence |
| William J. Brown, R.Ph. |
Cicero |
| Medhane Cumbay, Ph.D. |
Indianapolis |
| Philip N. Eskew, Jr., M.D. |
Chairperson |
North Webster
|
| Petra A. Fippen, R.Ph. |
Indianapolis |
| Thomas R. Marshall, M.D. |
Indianapolis |
| Rhea Ellen Miller-Boley, R.Ph. |
Nashville |
| Brian W. Musial, R.Ph. |
Pittsboro |
| Carol Ott, PharmD., BCPP |
Vice Chairperson |
Indianapolis
|
| Nancy Swigonski, M.D. |
Indianapolis |
| Patricia A. Treadwell, M.D. |
Indianapolis |
| John J. Wernert, M.D. |
|
Carmel |
DUR Board Duties
Contact the Board
Communication to the board should be directed to the following
email address: pdl@fssa.in.gov.
Pharmaceutical manufacturers with questions regarding the
state's supplemental rebate program should access relevant
information on the Pharmacy Benefit
Manager (PBM) website. The Supplemental Rebates menu
contains significant information about the supplemental rebate bid
submission processes.
Meeting Information
Agenda
FSSA Calendar Public
Notice/Agenda
Draft Meeting Minutes
Please note that minutes appearing on this site are presented in
a draft version. Readers need to refer to the "Approval of the
Minutes" section of the subsequent meeting for any corrections.
Speaker Sign-In Sheet
If you wish to speak at the Indiana Medicaid Drug Utilization
Review (DUR) Board, please sign your name on the sign-in sheet
provided at the meeting prior to its start. There is a two-minute
maximum time limit when addressing the board. When your name is
called, please stand, state your name and affiliation (if any), and
present your comments.
DUR Publications
PDL Evaluation Reports
Newsletters
Retrospective DUR Interventions
Archived DUR Publications
For more archived DUR publications, see the Archived DUR Publications
page of this website.